Serina Therapeutics, Inc. (SER)

Serina Therapeutics Statistics

Total Valuation

SER has a market cap or net worth of $20.06 million. The enterprise value is $14.72 million.

Market Cap	20.06M
Enterprise Value	14.72M

Important Dates

The next estimated earnings date is Monday, March 23, 2026, after market close.

Earnings Date	Mar 23, 2026
Ex-Dividend Date	n/a

Share Statistics

SER has 10.79 million shares outstanding. The number of shares has increased by 72.47% in one year.

Current Share Class	10.79M
Shares Outstanding	10.79M
Shares Change (YoY)	+72.47%
Shares Change (QoQ)	+3.35%
Owned by Insiders (%)	12.03%
Owned by Institutions (%)	4.22%
Float	5.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	177.47
Forward PS	n/a
PB Ratio	12.52
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	126.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 2.12.

Current Ratio	1.31
Quick Ratio	0.98
Debt / Equity	2.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-684.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-137.85%
Return on Invested Capital (ROIC)	-971.25%
Return on Capital Employed (ROCE)	-603.97%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	$8,923
Profits Per Employee	-$1.45M
Employee Count	13
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -61.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-61.41%
50-Day Moving Average	2.76
200-Day Moving Average	4.64
Relative Strength Index (RSI)	33.04
Average Volume (20 Days)	3,575,577

Short Selling Information

The latest short interest is 85,186, so 0.79% of the outstanding shares have been sold short.

Short Interest	85,186
Short Previous Month	36,399
Short % of Shares Out	0.79%
Short % of Float	1.60%
Short Ratio (days to cover)	0.93

Income Statement

In the last 12 months, SER had revenue of $116,000 and -$18.80 million in losses. Loss per share was -$1.92.

Revenue	116,000
Gross Profit	-12.00M
Operating Income	-21.89M
Pretax Income	-18.63M
Net Income	-18.80M
EBITDA	-21.78M
EBIT	-21.89M
Loss Per Share	-$1.92

Balance Sheet

The company has $8.62 million in cash and $3.39 million in debt, with a net cash position of $5.23 million or $0.49 per share.

Cash & Cash Equivalents	8.62M
Total Debt	3.39M
Net Cash	5.23M
Net Cash Per Share	$0.49
Equity (Book Value)	1.59M
Book Value Per Share	-0.30
Working Capital	2.71M

Cash Flow

In the last 12 months, operating cash flow was -$16.51 million and capital expenditures -$64,000, giving a free cash flow of -$16.58 million.

Operating Cash Flow	-16.51M
Capital Expenditures	-64,000
Free Cash Flow	-16.58M
FCF Per Share	-$1.54

Margins

Gross Margin	n/a
Operating Margin	-18,868.97%
Pretax Margin	-16,061.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SER does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-72.47%
Shareholder Yield	-72.47%
Earnings Yield	-94.24%
FCF Yield	-83.07%

Analyst Forecast

The average price target for SER is $13.00, which is 598.93% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	598.93%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SER has an Altman Z-Score of -9.42 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.42
Piotroski F-Score	2